Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Anti-Hypertensive Drugs Market From 2025 To 2029?

In recent times, there’s been a slight expansion in the anti-hypertensive drugs market size. It’s forecasted to escalate from $37.42 billion in 2024 to $38.03 billion in 2025, recording a compound annual growth rate (CAGR) of 1.6%. Factors such as environmental and lifestyle impacts, previous market competition, traditional treatment choices, economic circumstances, and past global health patterns have contributed to growth in the historic period.

The market size of anti-hypertensive drugs is anticipated to witness slight escalation in the coming years, expanding to $40.74 billion in 2029 with a compound annual growth rate (CAGR) of 1.7%. The increment during this forecast period can be ascribed to factors such as affordability and cost-effectiveness, the advent of therapeutic advancements, epidemiological transformations, policy changes and approvals in regulations, dynamics of the aging population, and amendments in healthcare policies and reimbursements. Key trends observed during this forecast period involve innovation in therapy, shifts in epidemiology, changes in regulatory frameworks, healthcare policies, and progress in diagnosis and monitoring procedures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anti-Hypertensive Drugs Market?

The surge in the anti-hypertensive drug market is largely due to a sedentary lifestyle. Eating fast food, not following a well-rounded and nutritious diet, and inadequate sleep caused by irregular work hours all contribute to the rise in hypertension. Hypertension is a contributing factor in roughly 45% of heart disease-related deaths and 51% of stroke-related deaths. After a hypertension diagnosis, patients need to use drugs to manage their hypertension, the type of which depends on the severity of the condition. For example, in May 2023, the National Health Service, a government department based in England, reported that the total hypertension prevalence grows with age—starting at 9% among adults aged 16 to 44 and increasing to 60% in those aged 65 and older. This trend ensures a consistent demand for these products, making it a major contributing factor to the market’s growth.

Which Key Market Segments Comprise the Anti-Hypertensive Drugs Market and Drive Its Revenue Growth?

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp

Which Areas Are Leading Regions in the Anti-Hypertensive Drugs Market Expansion Across the Globe?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theAnti-Hypertensive Drugs Market Over the Coming Years?

Premier enterprises in the anti-hypertensive drugs industry are centering their strategies on the development of innovative products like Metoprolol Succinate Extended-Release Tablets. Such inventions offer them a strategic advantage in the competitive marketplace. These tablets serve as anti-hypertensive medication for those suffering from high blood pressure. For example, in June 2023, an India-based pharmaceutical firm, Granules India Limited, introduced Metoprolol Succinate Extended-Release Tablets which have received approval from the Food and Drug Administration (FDA), a federal agency in the US. Launching Metoprolol Succinate Extended-Release Tablets as anti-hypertensive medication is a step forward in the battle against hypertension by controlling blood pressure. The tablets can be obtained at different strengths: 25mg, 50mg, 100mg, and 200mg. They incorporate beta-blockers, which can curtail the heart rate, ease the heart’s effort, and bring down blood pressure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

How Is the Anti-Hypertensive Drugs Market Conceptually Defined?

Anti-hypertensive drugs refer to a group of medications used to treat high blood pressure (high blood pressure). The goal of antihypertensive therapy is to prevent the negative effects of high blood pressure, such as myocardial infarction and stroke.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2410

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model